Cryosurgery for prostate cancer: Improved glandular ablation by use of 6 to 8 cryoprobes

Urology

Volumn 54, Issue 1, 1999, Pages 135-140

  Lee, F ^a   Bahn, Duke K ^b   Badalament, Robert A ^b   Kumar, Anil B ^b   Klionsky, David ^b   Onik, Gary M ^b   Chinn, Douglas O ^b   Greene, Christine ^b  

^a Crittenton Hospital Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CONTROLLED STUDY; CRYOSURGERY; DEVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY;

CRYOSURGERY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0033169108     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00039-4     Document Type: Article

References (18)

1. Onik GM, Cohen JK, Reyes GD, et al: Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72: 1291-1298, 1993.
2. Grampsas SA, Miller GJ, and Crawford ED: Salvage radical prostatectomy after failed transperineal cryotherapy: histologie findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology 45: 936-941, 1995.
3. Shuman BA, Cohen JK, Miller RJ Jr, et al. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate. J Urol 157: 552-555, 1997.
4. Shinohara K, Connolly JA, Presti JC, et al: Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol 156: 115-121, 1996.
5. Lee F, Bahn DK, McHugh TA, et al: Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring - a one year follow-up. Anticancer Res 17: 1511-1516, 1997.
6. Bahn DK, Lee F, Solomon MH, et al: Prostate cancer: US-guided percutaneous cryoablation. Radiology 190: 551-556, 1994.
7. Wong WS, Chinn DO, Chinn M, et al: Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 79: 963-974, 1997.
8. Cohen JK, Miller RJ, Rooker GM, et al: Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology 47: 395-401, 1996.
9. Miller RJ, Cohen JK, and Merlotti LA: Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 44: 170-174, 1994.
10. Lee F, Bahn DK, McHugh TA, et al: How I do it. US-guided percutaneous cryoablation of prostate cancer. Radiology 192: 769-776, 1994.
11. Onik GM: Saline injection into Denonvillier's fascia - eliminating the urethro-rectal fistula. Presented at the 10th Congress of Cryosurgery, Orlando, Florida, October 29-November 1, 1998.
12. Tatsutani K, Rubinsky B, Onik G, et al: Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 48: 441-447, 1996.
13. Siders DB, Lee F, and Mayman DM: Diagnosis of prostate cancer altered by ionizing radiation with and without neoadjuvant antiandrogen hormonal ablation, in Foster CS, and Bostwick DG (Eds): Pathology of the Prostate. Philadelphia, WB Saunders, 1998, vol 34, pp 315-320.
14. Bostwick DG, Egbert BM, and Fajardo LF: Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6: 541-551, 1982.
15. Connolly JA, Shinohara K, Presti JC Jr, et al: Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am 24: 415-420, 1997.
16. Critz FA, Levinson K, Williams WH, et al: Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer. Urology 49: 668-672, 1997.
17. Civantos F, Marcial MA, Banks ER, et al: Pathology of androgen deprivation therapy in prostate carcinoma. Cancer 75: 1634-1641, 1995.
18. Badalament RA, Bahn DK, Kim H, et al: Patient-reported complications after cryoablation therapy for prostate cancer. Urology (in press).